Galderma has announced the launch of Restylane Defyne and Restylane Refyne: the first Optimal Balance Technology (OBT)â...
India's OneSource Specialty Pharma has received Saudi Food and Drug Authority (SFDA) approval of its generic Oze...
Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...
Singapore-headquartered Zuellig Pharma has acquired all rights, title, and interest in and to the Zam-Buk® and Vapex...
Budapest-based Gedeon Richter Plc. and Japan's Fuji Pharma Co. have announced the expansion and further strengthening of...
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the termination of the current rocatin...
DHL Group has announced the expansion of its life sciences arm—DHL Health Logistics—with the development of ...
AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...
The Asian biopharma landscape is evolving rapidly and undergoing major shifts, expanding focus beyond generics and contr...
Why does TAXIS choose to focus on antimicrobial resistance? What are the key developments taking place at TAXIS to comba...
Life sciences M&A accelerated in 2025, with deal sizes increasing and total spend surpassing 2024 levels before the ...
Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirme...
AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...
Japan-based H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio have announced the availability of the Lu...
Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 c...
China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...
Palo Alto‑based PGxAI, a leader in AI-powered pharmacogenomics, and Saudi Arabia’s Novo Genomics&...
MS Pharma Group, a leading regional pharmaceutical company in the Middle East and North Africa (MENA) region, has signed...
Japan-based pharmaceutical firm Daiichi Sankyo has further established its presence in Canada with the official opening ...
GSK plc and Shionogi & Co. have reached an agreement together with Pfizer Inc. for the 11.7% economic interest in UK...
South Korea based Alteogen Inc. has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK. ...
D. Western Therapeutics Institute, Inc. (DWTI) has announced that Kowa Co., Ltd., to which DWTI out-licensed its in-hous...
US-based Pacira BioSciences, Inc. has entered into an agreement with South Korea's LG Chem designed to expand access to ...
US-based Rakuten Medical, Inc. and South Korea's Lotte Biologics have signed a biopharmaceutical contract manufacturing ...
Novartis, a leading global innovative medicines company, has announced plans to build its fourth US radioligand therapy ...
